The Phoenix Mills Ltd. (PDF)
Top Losers
Current IPOs
Closed IPOs
Listed IPOs
IPO Performers
CAGR Calculator
Adani Ports and SEZ
Suven Life Sciences Ltd. Share Price
Pharmaceuticals & DrugsSuven Life Sciences Ltd. (INR)247.0222.5 (10%) 
Exchange ScripsBSE530239NSESUVENISININE495B01038
Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks
Trendline of performance -
Suven Life Sciences Ltd. Performance
Market performance
Open price226.12
High247.02
Volumes1460988
Prev Close247.02
Low226.12
Closing date2025-06-11
Historical performance
1 Year High250.48
3 Year High250.48
5 Year High250.48
1 Year Low95.20
3 Year Low45.00
5 Year Low28.10
Suven Life Sciences Ltd. Fundamentals
Company Valuation
Market Cap (₹Cr)
NaN
Face Value (₹)
P/E Ratio
Dividend Yield
N/A
Suven Life Sciences Ltd. Investment Returns
1 Year
144.6%
3 Years
250.9%
5 Years
719.9%
10 Years
15.5%
Suven Life Sciences Ltd. Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 229.71 | Bullish |
| 10-DMA | 234.31 | Bullish |
| 20-DMA | 222.96 | Bullish |
| 50-DMA | 168.42 | Bullish |
| 100-DMA | 145.04 | Bullish |
| 200-DMA | 140.85 | Bullish |
Shareholding Pattern
| Field | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 | Mar-2024 |
|---|---|---|---|---|---|
| Promoters | 6 | 6 | 6 | 6 | 6 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 6 | 6 | 6 | 6 | 6 |
| Public Investors | 64597 | 63531 | 63969 | 66110 | 68953 |
| Government | --- | --- | --- | --- | --- |
Suven Life Sciences Ltd. Financials
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Other Income | 211 | 84 | 16 | 78 |
| Operating Profit | -1067 | -1173 | -1206 | -722 |
| Interest | 3 | 4 | 7 | 9 |
| Depreciation | 65 | 65 | 44 | 43 |
| Profit Before Tax | -1061 | -1183 | -1220 | -775 |
| Consolidated Net Profit | -1051 | -1183 | -1220 | -722 |
| Adjusted EPS | -5 | -5 | -8 | -5 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Share Capital | 218 | 218 | 145 | 127 |
| Total Reserves | 2482 | 3535 | 816 | 584 |
| Minority Interest | --- | --- | --- | --- |
| Total Non-Current Liabilities | 13 | 25 | 36 | 45 |
| Total Liabilities | 2849 | 4828 | 2019 | 2223 |
| Capital Work in Progress | --- | --- | 36 | 48 |
| Total Assets | 2849 | 4828 | 2019 | 2223 |
Cash Flow
Below figures are in Rs. Crores
| Particulars | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
| Cash Flow from Operating Activities | -1155 | -1160 | -1275 | -960 |
| Cash Flow from Investing Activities | 944 | -2478 | -222 | 558 |
| Cash Flow from Financing Activitie | -11 | 3955 | 1457 | 349 |
| Net Cash Inflow / Outflow | -221 | 317 | -41 | -53 |
0%
Negative
Neutral
Positive
- The stock has a PE ratio of -51.27.
- 3Y Stock Price CAGR of the stock is 52.9.
- The stock has a beta of 1.1.
- In the last financial year, the company had an EBITDA of ₹-1067 Million.
- The company generated revenue of ₹117 Million in the previous financial year.
Suven Life Sciences Ltd.
247.0222.5 (10%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 2472425.2
No. of Shares: 10009.0
Performance:147.2%
P/L: ₹1472425.2
Top Gainers
| Symbol | Change% |
|---|---|
| GTL | 11.18(20%) |
| KARMAENG | 69.55(20%) |
| ENERGYDEV | 26.53(20%) |
| GTLINFRA | 1.81(20%) |
| ANTGRAPHIC | 1.51(20%) |
Similar stocks
Announcing Stock of the Month!
Live video call With Our Agent